6-fluorometaraminol has been researched along with dihydroxyphenylalanine in 1 studies
*Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. [MeSH]
*Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. [MeSH]
| Studies (6-fluorometaraminol) | Trials (6-fluorometaraminol) | Recent Studies (post-2010) (6-fluorometaraminol) | Studies (dihydroxyphenylalanine) | Trials (dihydroxyphenylalanine) | Recent Studies (post-2010) (dihydroxyphenylalanine) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 8,823 | 322 | 833 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fowler, JS; Wolf, AP | 1 |
1 review(s) available for 6-fluorometaraminol and dihydroxyphenylalanine
| Article | Year |
|---|---|
The heritage of radiotracers for positron emission tomography.
Topics: Carbon Radioisotopes; Deoxyglucose; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Metaraminol; Tomography, Emission-Computed | 1990 |